Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The filing is a regulatory disclosure submitted under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30, Schedule III). The headline alone does not specify the actual event or material development being reported — only the regulatory clause under which the disclosure is made. The substantive content of the announcement (such as order wins, expansions, financial results, management changes, or any other corporate action) was not included in the provided information, so key details and numbers cannot be reported.
No impact on shareholders or stock price can be assessed from this filing alone, as the actual subject of the disclosure is missing. Investors should check the full announcement on the NSE/BSE website for the specific development.